Literature DB >> 30976547

Increased serum malondialdehyde levels are associated with grey matter volume loss in patients with non-alcoholic cirrhosis.

Wei Zheng1, Wen-Wei Zhu1, Zhi-Chao Feng1, Qi Liang1, Peng-Fei Rong1, Li-Feng Li1, Yun-Jie Liao1, Wei Wang1.   

Abstract

BACKGROUND: Grey matter volume (GMV) loss has been observed in patients with non-alcoholic cirrhosis, but the underlying mechanisms are unknown. Oxidative stress (OS) is a recognized feature and systemic phenomenon of cirrhosis. However, little is known about whether OS is associated with GMV loss in cirrhosis. This study aimed to assess the relationship between oxidative damage and GMV loss in patients with non-alcoholic cirrhosis.
METHODS: Thirty-four patients with non-alcoholic cirrhosis and 27 age- and sex-matched healthy controls were enrolled in this prospective study. All subjects underwent brain magnetic resonance imaging (MRI), and voxel-based morphometry (VBM) was performed to assess normalized global GMV. As an OS marker, serum malondialdehyde (MDA) levels were determined in all subjects. In the patient group, a correlation analysis was used to investigate the relationship between serum MDA levels and normalized global GMV.
RESULTS: Compared with healthy controls, cirrhotic patients displayed a significant decrease in normalized global GMV and a significant increase in serum MDA levels. In the patient group, serum MDA levels were negatively correlated with normalized global GMV adjusted for age, sex and Child-Pugh class.
CONCLUSIONS: Increased serum MDA levels were associated with GMV loss in patients with non-alcoholic cirrhosis, suggesting that oxidative damage may be involved in GMV loss observed in cirrhotic patients.

Entities:  

Keywords:  Cirrhosis; grey matter volume (GMV); malondialdehyde; oxidative stress

Year:  2019        PMID: 30976547      PMCID: PMC6414766          DOI: 10.21037/qims.2018.12.12

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  35 in total

Review 1.  Oxidants, oxidative stress and the biology of ageing.

Authors:  T Finkel; N J Holbrook
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

Review 2.  Oxidative stress in neurodegeneration: cause or consequence?

Authors:  Julie K Andersen
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

3.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.

Authors:  Roy G Cutler; Jeremiah Kelly; Kristin Storie; Ward A Pedersen; Anita Tammara; Kimmo Hatanpaa; Juan C Troncoso; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-15       Impact factor: 11.205

4.  Evaluation of plasma ammonia levels in patients with acute liver failure and chronic liver disease and its correlation with the severity of hepatic encephalopathy and clinical features of raised intracranial tension.

Authors:  Arun Kundra; Anil Jain; Alok Banga; Girish Bajaj; Premasish Kar
Journal:  Clin Biochem       Date:  2005-08       Impact factor: 3.281

Review 5.  Neuronal cell death in hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 6.  Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; James B Wade; Arun J Sanyal
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

Review 7.  Oxidative stress and neurodegeneration: where are we now?

Authors:  Barry Halliwell
Journal:  J Neurochem       Date:  2006-06       Impact factor: 5.372

8.  Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease.

Authors:  P Ljubuncic; Z Tanne; A Bomzon
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

9.  Oxidant stress is a significant feature of primary biliary cirrhosis.

Authors:  Ali Aboutwerat; Philip W Pemberton; Alexander Smith; Peter C Burrows; Raymond F T McMahon; Sanjiv K Jain; Thomas W Warnes
Journal:  Biochim Biophys Acta       Date:  2003-03-20

10.  GABAC receptor agonist suppressed ammonia-induced apoptosis in cultured rat hippocampal neurons by restoring phosphorylated BAD level.

Authors:  Li Yang; Kyoko Omori; Koichiro Omori; Hitomi Otani; Junko Suzukawa; Chiyoko Inagaki
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

View more
  2 in total

1.  Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.

Authors:  Muhammed Majeed; Shaheen Majeed; Kalyanam Nagabhushanam; Lincy Lawrence; Lakshmi Mundkur
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

2.  Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients.

Authors:  Patrick Buosi; Fábio Aparecido Borghi; Angélica Marta Lopes; Isabela da Silva Facincani; Rafael Fernandes-Ferreira; Camila Ive Ferreira Oliveira-Brancati; Tayanne Silva do Carmo; Dorotéia Rossi Silva Souza; Danilo Grünig Humberto da Silva; Eduardo Alves de Almeida; Gerardo Maria de Araújo Filho
Journal:  Trends Psychiatry Psychother       Date:  2021-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.